virus
requir
viral
protein
form
new
particl
process
depend
cellular
translat
machineri
therefor
virus
develop
mechan
favor
synthesi
protein
cellular
protein
synthesi
differ
studi
suggest
possibl
role
translat
initi
factor
viral
infect
complex
one
wide
studi
translat
initi
factor
commonli
use
certain
virus
consist
statement
protein
part
complex
regul
viral
infect
way
regul
accomplish
tend
differ
case
mean
virus
either
use
use
may
altern
requir
requir
protein
synthesi
protein
translat
divid
three
elong
object
translat
inform
contain
mrna
accord
form
initi
translat
classifi
capdepend
capindepend
cellular
mrna
character
structur
end
call
cap
end
contain
polyadenyl
tract
poli
bound
poli
bind
protein
pabp
capdepend
mechan
mrna
recruit
protein
complex
call
compos
three
protein
capbind
protein
helicas
turn
join
initi
factor
like
anoth
complex
particip
initi
phase
call
form
small
ribosom
subunit
factor
ternari
complex
form
turn
gtp
trnamethionineiniti
mettrnai
complex
recruit
complex
interact
ribosom
subunit
carri
complex
start
codon
aug
ribosom
subunit
bind
give
rise
full
ribosom
protein
releas
togeth
gdp
elong
step
start
fig
factor
deadbox
helicas
compos
two
recalik
domain
flexibl
central
hing
region
factor
part
complex
also
compos
complex
describ
key
element
capdepend
translat
initi
process
highli
regul
step
one
function
recruit
mrna
translat
howev
eukaryot
mrna
present
secondari
structur
region
make
translat
difficult
due
abil
prevent
assembl
ribosom
subunit
complic
scan
near
start
codon
role
helicas
activ
unwind
utr
structur
number
studi
suggest
weak
helicas
activ
activ
stimul
initi
factor
present
addit
remov
adher
protein
heterogen
ribonucleoprotein
molecul
cellular
nucleu
commonli
coat
mrna
recent
consid
sole
could
remov
structur
within
mrna
protein
biosynthesi
recent
specif
research
found
higher
import
even
function
regul
differ
level
one
event
particip
assembl
stress
granul
sg
granul
cytoplasm
aggreg
cellular
translat
arrest
stress
condit
review
initi
sg
suggest
assembl
respons
phosphoryl
translat
factor
howev
recent
studi
shown
sg
also
form
consequ
inactiv
discoveri
drug
pateamin
favor
bind
mrna
way
function
inhibit
sg
form
result
propos
import
protein
synthesi
control
consequ
regul
gene
express
translat
level
recent
differ
research
team
use
initi
factor
therapeut
target
cancer
viral
infect
obtain
promis
interest
result
mechan
known
capindepend
presenc
structur
known
intern
ribosom
entri
site
ire
within
import
translat
mrna
mechan
initi
describ
trait
picornaviru
famili
howev
known
iress
found
exclus
viral
mrna
observ
initi
form
mrna
ire
becom
translat
without
requir
canon
initi
happen
cricket
paralysi
viru
famili
dicistrovirida
genu
cripaviru
may
translat
one
canon
factor
use
cellular
protein
known
ire
transact
factor
itaf
alreadi
describ
viral
iress
virus
employ
translat
mechan
mrna
similar
use
cellular
mrna
reason
virus
draw
mechan
ensur
stabil
format
one
exampl
cytomegaloviru
code
protein
known
whose
target
fig
demonstr
vitro
bind
ensur
remain
recruit
within
thu
prevent
sequest
regul
protein
addit
ensur
format
cytomegaloviru
stimul
synthesi
compon
complex
influenza
viru
known
mrna
characterist
similar
cellular
mrna
use
synthes
protein
experiment
model
vitro
vivo
evid
viru
need
addit
fig
princip
function
remov
complex
secondari
structur
mrna
regardless
way
ribosom
unit
recruit
function
helicas
crucial
capdepend
translat
part
complex
also
capindepend
translat
viral
mrna
via
ire
consist
encephalomyocard
viru
ire
found
use
initi
mechan
depend
structur
conform
chang
requir
downstream
region
initi
codon
mediat
fig
evid
particip
translat
viral
ire
mrna
establish
occas
associ
factor
complex
necessari
ire
kaposi
sarcomaassoci
herpesviru
caliciviru
mrna
fig
although
import
bind
translat
factor
fulli
understood
clear
interact
increas
translat
effici
viru
evolv
differ
previous
mention
virus
employ
classic
capdepend
translat
mechan
one
canon
factor
manipul
case
viral
mrna
name
hantaviru
translat
take
place
via
capdepend
mechan
function
substitut
viral
protein
name
n
make
protein
even
interest
fact
also
play
role
advantag
n
function
substitut
function
also
abl
differenti
viral
cellular
mrna
favor
viral
mrna
consequ
format
new
viral
particl
fig
case
show
great
divers
multipl
function
viral
protein
cotesia
plutella
bracoviru
cpbv
dna
viru
famili
polydnavirida
genu
bracoviru
inhibit
cellular
mrna
translat
infect
cell
viral
protein
target
found
viral
protein
term
synthes
late
phase
infect
protein
region
homolog
characterist
bind
sequest
thu
avoid
format
fig
late
phase
infect
mrna
translat
contain
secondari
structur
utr
would
present
viral
mrna
result
select
cellular
mrna
cellular
initi
factor
pabp
report
target
code
proteas
virus
evid
target
viral
proteas
case
proteas
code
foot
mouth
diseas
viru
proteas
also
cut
make
capabl
gener
synerg
effect
due
cut
factor
result
decreas
cellular
protein
synthesi
via
capdepend
mechan
wherea
viral
protein
synthesi
take
place
via
capindepend
mechan
fig
research
address
role
transdomin
mutant
hippuristanol
specif
inhibitor
prevent
bind
mrna
confirm
mrna
ire
virus
resist
condit
suggest
independ
translat
process
case
hepat
c
viru
classic
swine
fever
viru
porcin
teschoviru
type
cricket
paralysi
virus
interest
exampl
versatil
viral
mrna
concern
translat
requir
messeng
rna
altern
among
differ
translat
mechan
depend
current
context
sindbi
viru
one
exampl
infect
cell
cell
transfect
replicon
viru
viral
protein
synthesi
independ
howev
genom
subgenom
mrna
transfect
cell
via
vector
express
complet
depend
presenc
viral
protein
could
supplant
function
infect
experiment
discard
result
studi
suggest
sindbi
viru
mrna
capabl
adapt
differ
condit
depend
avail
translat
initi
factor
genom
mrna
human
immunodefici
viru
type
hiv
two
aug
start
codon
allow
synthesi
two
isoform
gag
protein
codon
gener
isoform
translat
via
capdepend
mechan
use
switch
capindepend
mechan
ire
structur
present
utr
codon
gener
isoform
translat
via
capindepend
mechan
ire
found
gag
orf
altern
behavior
capdepend
capindepend
translat
codon
suggest
viral
mrna
translat
accord
intracellular
condit
avail
initi
factor
order
secur
viral
protein
synthesi
compound
characterist
inhibit
silvestrol
hippuristanol
elisabatin
allolaurintenol
rocaglamid
pateamin
deriv
compound
emerg
new
antivir
therapeut
strategi
whose
mechan
action
inhibit
consist
silvestrol
shown
antivir
activ
vitro
rna
virus
ebola
viru
hepat
e
coronaviru
rhinoviru
polioviru
hippuristanol
test
preclin
studi
possibl
use
patient
therefor
use
compound
inhibit
activ
hold
great
interest
virolog
antivir
agent
despit
import
role
intracellular
event
avail
inform
protein
particip
viral
infect
scarc
protein
particip
capdepend
translat
part
complex
paradox
also
particip
capindepend
translat
via
ire
viral
infect
fact
particip
replic
cycl
virus
make
use
control
infect
date
compound
known
specif
effect
experiment
use
compound
shown
interest
result
anim
studi
model
relat
preclin
studi
serv
foundat
use
hippuristanol
therapeut
treatment
could
use
viral
infect
high
import
viral
replic
